Advanced Hybrid Closed-Loop vs. 670G in T1D
Key messages
- In this first comparative trial of approved devices for automated insulin delivery, Advanced Hybrid Closed-Loop was superior to MINIMED 670G in reducing daytime hyperglycemia without increasing hypoglycemia.
- Both systems were safe.
- Advanced Hybrid Closed-Loop was superior to 670G for 24-hour glucose time in range of 70-180 mg/dL, reducing HbA1c and overall treatment satisfaction.